You are here

FDA Issues Risk Alert About Bulk Drug Substance Cesium Chloride

Part of an ongoing effort to better oversee use of compounded medications.

In its continuing effort to ensure the safety and efficacy of compounded medications, the FDA yesterday issued a compounding risk alert about cesium chloride, which is sometimes used by cancer patients. The alert, issued to providers and patients, states that “serious adverse events associated with the use of cesium chloride and other cesium salts include abnormal heart rhythms (arrhythmias), low potassium (hypokalemia), seizures, fainting (syncope), cardiac arrest and death.”

Recent Headlines

Study shows "complex genetic risk architecture"
Study says yes, interventions cuts need for meds
Review of 18 studies finds that medium doses have the strongest effects
Research suggests that stress mitigation could be an effective intervention strategy
Children, parents with ADHD benefit from parenting intervention
More research is needed to confirm the finding
A new 'road map' might make it easier
Rationing, canceled treatments, and fearful patients